Alexandra K. Heyl (Allie)

Associate

Washington + 1.202.879.3431

Connect:

Share

Allie Heyl advises clients on government contracting, international trade, and national security matters.

Allie counsels and represents clients in bid protests before the Government Accountability Office (GAO) and the U.S. Court of Federal Claims (COFC); Department of Justice (DOJ) investigations and False Claims Act (FCA) matters; tariff issues before Customs and Border Protection (CBP); and cross-border transactions reviewed by the Committee on Foreign Investment in the United States (CFIUS).

Allie helps clients navigate the Federal Acquisition Regulation (FAR), understand subcontracting obligations, and comply with related rules, including federal antidiscrimination laws, the Byrd Anti-Lobbying Amendment, and the Build America, Buy America Act (BABA). Allie also assists with business transactions implicating the International Traffic in Arms Regulations (ITAR), the Export Administration Regulations (EAR), and Office of Foreign Assets Control (OFAC) sanctions.

Experience

  • Aludyne divests certain North American business assets to LinamarJones Day advised Aludyne, Inc. in a complex, distressed M&A transaction that required coordinated negotiations with the company’s secured lenders, key customers, and other critical stakeholders to secure forbearances and near-term liquidity during the sale process.
  • Inflexion acquires Veto Pro PacJones Day advised Inflexion Private Equity and its portfolio company Aspen Pumps Limited on the acquisition of Veto Pro Pac, LLC, a manufacturer of a premium range of tool bags and tool storage solutions.
  • Morgan Stanley portfolio company acquires Richard Heath & AssociatesJones Day advised Morgan Stanley Capital Partners in the acquisition and financing by portfolio company Resource Innovations, Inc. of Richard Heath & Associates, Inc.
    • View All

    October 2025 Alert

    New Legislation Expected to Increase Congressional Oversight of U.S. Export Controls

    OCTOBER 2025 Alert

    United States Expands Reach of Export Controls Entity List

    September 2025 Newsletters

    Innovative Insights: Legal Updates in Life Sciences | Third Quarter 2025

    September 2025 Newsletters

    Preparing for Pharmaceutical Tariffs: What Industry Can Do To Mitigate Supply Chain Risks

    March 2025 Alert

    Proposed California Legislation Aims to Phase Out Ultra-Processed Foods From School Meals

    December 2024 Commentary

    FDA's Digital Health Advisory Committee Discusses Total Product Lifecycle Considerations for GenAI-Enabled Devices

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.